BC patients with overexpression of Human epidermal growth factor receptor 2 (HER2) have shown a poorer and shorter overall survival (OS) 2, 3 being HER2 expression a predictor of metastatic BC 4. This evidence concerns the gene ERBB2 and breast cancer.